Table of Contents

Schizophrenia is a relatively common disease whose lifetime prevalence in the general population is reported to be about 1%. From the perspective of public health, the illness has been associated with serious consequences. Besides psychotic symptoms, schizophrenia is characterized by disturbances of cognitive function, which is considered to largely determine the outcome of patients. The neural and genetic substrates underlying its pathophysiology have not been fully demarcated, posing a challenge for the development of breakthrough therapeutics. This book provides key information about the latest endeavor to solve these difficulties characterizing this enigmatic disease. (Imprint: Nova)